作者: Nima Etminan , Mervyn D. I. Vergouwen , R. Loch Macdonald
DOI: 10.1007/978-3-7091-1192-5_8
关键词:
摘要: Background and purpose: Despite a significant reduction of angiographic vasospasm, the poor functional outcome in clinical trials on aneurysmal subarachnoid hemorrhage (SAH) remains challenging. While there is general consensus that vasospasm associated with delayed cerebral ischemia (DCI), infarction, outcome, mortality after SAH, causal relationships are subject to discussion. Therefore, it was aim our study investigate relationship between various measures pharmaceutical treatment SAH.